ESR1 and breast carcinoma: Further analysis of the mRNA-seq data set found that GFRA1 is also strongly correlated with ESR1 mRNA in breast cancers (Spearman’s ρ = 0.52, p < 2.2e-16; S3A Fig), suggesting that it is also a direct target of E2 signaling.